Seizure activity results in increased tyrosine phosphorylation of the N-methyl-D-aspartate receptor in the hippocampus

Molecular Brain Research

Volumn 95, Issue 1-2, 2001, Pages 36-47

  Moussa, Raffy C ^a,b   Ikeda Douglas, Candace J ^a   Thakur, Varsha ^a   Milgram, Norton W ^a,b   Gurd, James W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Hippocampus; NMDA receptor; Postsynaptic density; PSD 95; Status epilepticus; Tyrosine phosphorylation

Indexed keywords

AMPA RECEPTOR; DEOXYCHOLIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPILEPTIC STATE; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SEIZURE; SOLUBILITY;

ANIMALS; BLOTTING, WESTERN; DETERGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HIPPOCAMPUS; KAINIC ACID; MALE; PHOSPHORYLATION; PRECIPITIN TESTS; RATS; RATS, LONG-EVANS; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; SOLUBILITY; TYROSINE;

EID: 0035500396     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(01)00231-5     Document Type: Article

References (65)

1. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy
2. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: Metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy
3. Src-mediated tyrosine phosphorylation of NR2 subunits of N-methyl-D-aspartate receptors protects from calpain-mediated truncation of their C-terminal domains
4. Regional distribution and time-course of calpain activation following kainate-induced seizure activity in adult rat brain
5. Relationship between N-methyl-D-aspartate receptor NR1 splice variants and NR2 subunits
6. Fyn tyrosine kinase is required for normal amygdala kindling
7. Long-term effects of intrahippocampal kainic acid injection in rats: A method for inducing spontaneous recurrent seizures
8. Glutamate receptors in epilepsy
9. Protein tyrosine kinase-mediated potentiation of currents from cloned NMDA receptors
10. Altered association of protein tyrosine kinases with postsynaptic densities after transient cerebral ischemia in the rat brain
11. Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus
12. Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage
13. Status epilepticus in the limbic system: Biochemical and pathological changes
14. Basic mechanisms of status epilepticus
15. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A
16. Excitatory amino acid receptors in epilepsy
17. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease
18. Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist
19. Neuroprotective effect of ketamine administered after status epilepticus onset
20. Intracellular calcium accumulation in rat hippocampus during seizures induced by bicuculline or L-allylglycine
21. Status epilepticus: The reversibility of calcium loading and acute neuronal pathological changes in the rat hippocampus
22. Procedures for analyzing the tyrosine phosphorylation of synaptic glycoproteins
23. The N-methyl-D-aspartate receptor subunits NR2A and NR2B bind to the SH2 domains of phospholipase C-gamma
24. 14C-2-deoxyglucose method
25. Biochemical evidence for the co-association of three N-methyl-D-aspartate (NMDA) R2 subunits in recombinant NMDA receptors
26. Phosphorylation-dependent interaction of the N-methyl-D-aspartate receptor epsilon 2 subunit with phosphatidylinositol 3-kinase
27. Selective loss of early suppression in the dentate gyrus precedes kainic acid induced electrographic seizures
28. Accumulation of calcium in substantia nigra lesions induced by status epilepticus. A microprobe analysis
29. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits
30. Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family
31. Higher seizure susceptibility and enhanced tyrosine phosphorylation of N-methyl-D-aspartate receptor subunit 2B in fyn transgenic mice
32. Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits
33. Epileptogenic effects of status epilepticus
34. Recurrent spontaneous hippocampal seizures in the rat as a chronic sequelal to limbic status epilepticus
35. Kainic acid induced limbic seizures: Metabolic, behavioral, electroencephalographic and neuropathological correlates
36. The role of glutamate in epilepsy and other CNS disorders
37. Glutamate receptors and transporters in genetic and acquired models of epilepsy
38. Tyrosine phosphorylation of NMDA receptor in rat striatum: Effects of 6-OH-dopamine lesions
39. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein
40. Changes in inhibitory processes in the hippocampus following recurrent seizures induced by systemic administration of kainic acid
41. Fyn-kinase as a determinant of ethanol sensitivity: Relation to NMDA-receptor function
42. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
43. The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B
44. Molecular cloning and characterization of the rat NMDA receptor
45. Kainic acid as a tool for the study of temporal lobe epilepsy
46. Molecular diversity of glutamate receptors and implications for brain function
47. Characterization of Fyn-mediated tyrosine phosphorylation sites on GluRepsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor
48. Delayed neuronal death in ischemic hippocampus involves stimulation of protein tyrosine phosphorylation
49. Excitatory transmitters and epilepsy-related brain damage
50. Kainic acid: A powerful neurotoxic analogue of glutamate
51. In vitro status epilepticus causes sustained elevation of intracellular calcium levels in hippocampal neurons
52. NMDA receptor activation during status epilepticus is required for the development of epilepsy
53. NMDA receptor and the tyrosine phosphorylation of its 2B subunit in taste learning in the rat insular cortex
54. Long-term potentiation increases tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit 2B in rat dentate gyrus in vivo
55. Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation
56. A role for Src kinase in spontaneous epileptiform activity in the CA3 region of the hippocampus
57. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein
58. On the relationship between kainic acid-induced epileptiform activity and hippocampal neuronal damage
59. The effect of transient global ischemia on the interaction of Src and Fyn with the N-methyl-D-aspartate receptor and postsynaptic densities: Possible involvement of Src homology 2 domains
60. Altered interaction between PSD-95 and the NMDA receptor following transient global ischemia
61. Transient ischemia differentially increases tyrosine phosphorylation of NMDA receptor subunits 2A and 2B
62. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A
63. Regulation of NMDA receptors by tyrosine kinases and phosphatases
64. Pathophysiological mechanisms of brain damage from status epilepticus
65. Kainate-induced seizures alter protein composition and N-methyl-D-aspartate receptor function of rat forebrain postsynaptic densities